|Study Description:||The goal of this clinical research study is to learn if the combination of |
azacitidine and GM-CSF can help to control MDS. The safety of these drugs will
also be studied.
Azacitidine is designed to block certain proteins that stop the function of
tumor-fighting genes. By blocking the "bad" proteins, the tumor-fighting genes
may be able to work better.
Granulocyte-macrophage colony-stimulating factor (GM-CSF) is designed to help
produce white blood cells. This may help to fight infections.